Föreskrifter (HSLF-FS 2020:13) om ändring i Läkemedelsverkets föreskrifter (LVFS 2011:10) om förteckningar över narkotika

1 1 Senast ändrade genom HSLF-FS 2020:1.

HSLF-FS 2020:13

ng

– – – – – – – – –

rkni ä

– – – – – – – – –

Anm

– – – – – – – – – – – –

– – – – – – – – – I – – P II – – – – – – – – – förteckning – – –

Internationell

– – – – – –

– – – – I I– I – – – – IN I– I – – – –

ensk v S

– – – – – – – – –

förteckning

– – – – – – – – –

– – – – – – – – – – – –

– – – – – – – – –

– – – – – – – – –

oxifenetylamin – – – – – – – – – – – – idin-1-yl)butan-1-on idin-1-yl)heptan-1-on 1-(5-kloropentyl)-1H-

– – – l-1-fenyl-2-(pyrrolidin-1- – – – – – – pyrrol y pyrrol

Entydigt kemiskt namn

ex – – – -2-( -2-( – – – – – – tanamid

-cykloh – – – – 1-fenyl 2 yl)etan-1-on 1-fenyl – – – – N-fenyl-N-[1-(2-fenyletyl)piperidin-4- yl]bu N-(adamantyl)- indazol-3-karboxamid 4-bromo-2,5-dimet – – – –

n – – – – – – – – –

Ämne

– – – – – – – – –

– – – – – – – – – – – –

ndra vanligt A

– – – – – – – – – fa-PBP fa-PEP

förekommande nam

Al Alfa-PCYP Al Butyrfentanyl 5C-AKB48 2C-B – – – – – – – – –

– – – – – – – – –

– – – – – – – – – – – –

– – – – – – – – –

INN-benämning

2 – – – – – –

– – – – – – – – –

– – – – – – – – –

– – – – – – – – – – – –

– – – – – – – – – – – – – – – – – – – – – – – – – – – – –

– – – – I I– I– – – – – I– I– I– I – – – –

– – – – – – – – –

– – – – – – – – –

– – – – – – – – – – – – pan-2-yl)- 5- – – – – – – – – – nylpro – – – – – – -fe – – –

do[4,3-b]indol-1-on – – – – – – – – l)-2-(2 – – – – n-2-yl)-1-(5-fluoropentyl)- n-2-yl)-1-(5-fluoropentyl)- ty

– – – – – – – – – tyl)-1H-indazol-3-karboxamid exylme – – – n – – – – – – loh amino-3-metyl-1-oxobutan-2-yl)-1-(5- pe 2-fenylpropan-2-yl)-5-pentyl-2, -(1- -(2-fenylpropa -(2-fenylpropa -( – – – – 2,5-dimetoxi-4-propylfenetylamin N kloro 5-(1,1-dimetylhexyl)-2-((1R,3S)-3- hydroxicyklohexyl)-fenol – – – – N 1H-pyrrolo[2,3-b]pyridin-3-karboxamid N 1H-indazol-3-karboxamid 5-(cyk 2,5-dihydro-1H-pyri 2 – – – –

– – – – – – E – – – N O – – – – – – E CL – – – N O – – – – – – L – – – – – PeGA – L- AC L- – – – – – – MY MG MY – – –

2C-P 5Cl-AB-PINACA CP 47,497-C6 CUMYL-5F-P7AICA CUMYL-5F-PINACA CU CH CU – – – – – – – – –

– – – – – – – – –

– – – – – – – – – – – –

– – – – – – – – – – – – – – – 3

HSLF-FS 2020:13

– – – – – – – – –

– – – – – – – – –

– – – – – – – – – – – –

– – – I – – – I – – – I I –

– – – – – – – – – – – –

– – – – – –

– – – – I– I– I– IP I– I– I– – – – – IP I– I – – – –

– – – – – – – – –

– – – – – – – – –

– – – – – – – – – – – –

– – – – – – – – – l)-1H-indazol-3y – – – – – – – – – tyl)-1H-indol-3utyl)-1H-indazol-3- )-5-(5-fluoropentyl)- en do[4,3-b]indol-1-on 1H-indol-3-karboxamid oropent – – – – – – – – – – – – ,3-dimetylbutanoat dimetyl-1-oxobutan-2-yl)- ,3-dimetylbutanoat ,3-dimetylbutanoat fluorop – – – 4-fluorob fluoropentyl)-1H-indazol-3- – – – – – – -( 1 t .1.13,7]dek-1-yl-1H-indazol-3on – – – – – – n – – – 2-[ l- l-2-[1-(5y -(1-amino-3,3- – – – – Met karboxamido]-3 N 1-(5-fluoropentyl)- Adamantyl-1-(5-flu karboxyla 1-(5-fluoropentyl)-N-tri- cyklo[3.3 karboxamid 2-(2-fenylpropan-2-yl 2,5-dihydro-1H-pyri Etyl-2-[1-(5- karboxamido]-3 Mety karboxamido]-3 – – – – Naftalen-1-yl-(1-pentylindol-3-yl)metanon Naftalen-1-yl(1-pentyl-1H-indol-3- yl)meta (Naftalen-1-yl)[1-(pent-4-en-1-yl)-1H- indol-3-yl]metanon Naftalen-1-yl-(1-butylindol-3-yl)metanon – – – –

– – – – – – – – –

CA – – – – – – – – – NA

– – – -BI – – – – – – – B – – 57

4 – – – – – –

– – – – – – – – – – – –

– – – – – – – – – – – –

– – – – – – – – – – – – – – – –

– – – – – – IV – – – – – – I + P I – N I – – – – – – – – – – – – – – – – – – – – – – – –

– – – – I– I– I – – – – I– IN – – – – I– I– I – – – – II

– – – – – – – – – – – –

– – – – – – – – – – – –

2- – – – – -( – – – – – – – – – – – – N – – – l]- – – – – – – – – – n y o zepin – – – in-4- – – – – – – – – – d

butan-1iperi d – – – – p – – – – – – – – – – – – -yl] 4-metyl-5-fenyl-2-oxazolin 1 yl) ami -[1-(5-fluoropentyl)-1H-

– – – – – – oxamido]propanoat – – – oxylat – – – )acet erazin- fenylet yl – – – p n – – – – – – – – – lpi lfe l-3-fenyl-2 y y er) [1-(2- – – – – 1-[4-(3-fenylprop-2-en-1-yl)-2- met N- met (±)-cis-2-amino- – – – – Mety indol-3-karb 1-metyl-4-fenyl-4-piperidinolpropionat (est – – – – 6-fenyl-1-metyl-8-nitro-4H[1,2,4] triazol[4,3-a][1,4]bensodia Naftalen-1-yl-1-(5-fluoropentyl)-1H- indol-3-karb 3-[2-(dipropylamino)etyl]indol – – – –

– – – – – – – – – – – –

– – – – – – – – – – – – entanyl lf y – – – – – – – – – – – – – – – – lacet -N-oxid y n – – – – – – – – – – – –

2-metyl-AP-237 2-met 4-metylaminorex Morfi MPhP-2201 MPPP Nitrazolam NM-2201 N,N-dipropyltryptamin DPT – – – – – – – – – – – –

– – – – – – – – – – – –

– – – – – – – – – – – – – – – –

– – – – – – – – – – – –

– – – – – – – – 5

HSLF-FS 2020:13

– – – – IN I– – – – – IV

-klo – – – – N-fenyl-N-[1-(2-fenyletyl)piperidin-4- yl]tetrahydrofuran-2-karboxamid N-fenyl-N-[1-(2-fenyletyl)piperidin-4-yl]- 2,2,3,3-tetrametylcyklopropan-1- karboxamid 7 dihydro-1-metyl-2H-1,4-bensodiazepin-2-on – – – –

Tetrahydrofuranfentanyl TH Tetrametylcyklopropyl- fentanyl

6 – – Tetrazepam – –

Dessa föreskrifter träder i kraft den 28 april 2020. Läkemedelsverket NILS GUNNAR BILLINGER Joakim Brandberg

HSLF-FS kan laddas ner via Läkemedelsverket. Webb: www.lakemedelsverket.se

Författningen kan beställas via: Norstedts Juridik 106 47 Stockholm

SVANENMÄRKET

Telefon: 08-598 191 90 E-post: kundservice@nj.se

3041 0123Trycksak

Internet: www.nj.se/offentligapublikationer

Elanders Sverige AB, 2020